Aquestive therapeutics completes $45 million debt refinancing

Warren, n.j., nov. 02, 2023 (globe newswire) -- aquestive therapeutics, inc. (nasdaq:aqst), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the refinancing of its existing debt facility.

AQST Ratings Summary

AQST Quant Ranking